Predictors of Response for “Off” Time Improvement With Levodopa-Carbidopa Intestinal Gel Treatment: An Analysis of the GLORIA Registry
Background: Levodopa-carbidopa intestinal gel (LCIG) is a long-term therapy for motor fluctuations in patients with advanced Parkinson's disease (PD). The aim of this analysis was to identify the baseline characteristics that predict “Off” time reduction in advanced PD patients treated with LCI...
Main Authors: | Werner Poewe, Lars Bergmann, Weining Z. Robieson, Angelo Antonini |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2020.00419/full |
Similar Items
-
A post hoc comparison of levodopa-carbidopa intestinal gel daytime monotherapy vs polytherapy safety and efficacy in patients with advanced Parkinson's disease: Results from 6 phase 3/3b open-label studies
by: James T. Boyd, et al.
Published: (2020-01-01) -
Apraxia of eyelid opening might be critical for levodopa-carbidopa intestinal gel treatment
by: Hiroshi Kataoka, et al.
Published: (2020-01-01) -
LEVODOPA-CARBIDOPA INTESTINAL GEL THERAPY IN PARKINSON’S DISEASE: PROCEDURE COMPLICATIONS
by: Luminita Celia POPA, et al.
Published: (2020-06-01) -
What can we learn from the effect of trihexyphenidyl on motor fluctuations during continuous levodopa-carbidopa intestinal gel infusion (LCIG)? – First documented case
by: Shin-ichiro Kubo, et al.
Published: (2020-01-01) -
EFFICACY, SAFETY AND PATIENT’S QUALITY OF LIFE OF LONG-TERM TREATMENT WITH LEVODOPA-CARBIDOPA INTESTINAL GEL IN ADVANCED PARKINSON’S DISEASE IN ROMANIA: RESULTS FROM GLORIA OBSERVATIONAL STUDY
by: Jozsef SZASZ, et al.
Published: (2020-03-01)